RecruitingPhase 1Drug trialA Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological MalignanciesA study to evaluate the safety and tolerability of INCA036873 in participants with advanced solid tumors and hematological malignancies.